Barinthus Biotherapeutics (BRNS) Interest Coverage Ratio (2020 - 2026)
Barinthus Biotherapeutics' (BRNS) quarterly Interest Coverage Ratio came in at 0.44 in Q1 2026, up 67.06% YoY from 0.26 in Q1 2025, and up 99.95% on a QoQ basis from 889.62 in Q4 2025.
Barinthus Biotherapeutics (BRNS) Interest Coverage Ratio (2020 - 2026) Analysis & Trends
Barinthus Biotherapeutics (BRNS) has 7 years of Interest Coverage Ratio data on file, last reported at 0.44 in Q1 2026.
- Quarterly Interest Coverage Ratio rose 67.06% year-over-year to 0.44 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 4.03 (up 12.65% YoY) and the FY2025 annual result came in at 1.52, up 30.88% from the prior year.
- Interest Coverage Ratio climbed to 0.44 in Q1 2026, from 889.62 in the prior quarter.
- In the past five years, Interest Coverage Ratio ranged from a high of 16.19 in Q4 2022 to a low of 2855.43 in Q4 2023.
- A 5-year average of 335.66 and a median of 1.09 in 2024 frame the typical range for Interest Coverage Ratio.
- Annual changes were most pronounced in 2022 — Interest Coverage Ratio soared 114.4% — and 2023, when it sank 17738.04%.
- Tracing BRNS's Interest Coverage Ratio over 5 years: stood at 16.19 in 2022, then slumped by 17738.04% to 2855.43 in 2023, then surged by 31.74% to 1949.17 in 2024, then jumped by 54.36% to 889.62 in 2025, then surged by 99.95% to 0.44 in 2026.
- The last three Interest Coverage Ratio figures came in at 0.44 (Q1 2026), 889.62 (Q4 2025), and 4.65 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.76 Bn | 131.91 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 86.51 Bn | 78.51 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 65.74 Bn | 60.56 Bn | 1.37 Bn | - |
| 4 | Moderna | 59.39 Bn | 54.26 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 42.24 Bn | 37.15 Bn | 1.53 Bn | 8.18 |
| 6 | Alnylam Pharmaceuticals | 31.78 Bn | 28.47 Bn | 992.69 Mn | 2.82 |
| 7 | BioNTech SE | 28.65 Bn | 10.26 Bn | 668.28 Mn | 76.86 |
| 8 | Insmed | 27.58 Bn | 26.42 Bn | 358.27 Mn | -0.08 |
| 9 | Royalty Pharma | 27.22 Bn | 26.39 Bn | - | 1.42 |
| 10 | Barinthus Biotherapeutics | 25.29 Mn | 25.29 Mn | - | -787.07 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.85 |
| Mar 31, 2026 | -0.44 |
| Dec 31, 2025 | -889.62 |
| Sep 30, 2025 | -4.65 |
| Jun 30, 2025 | -1.51 |
| Mar 31, 2025 | -1.33 |
| Dec 31, 2024 | -1,949.17 |
| Sep 30, 2024 | -0.56 |
| Jun 30, 2024 | -1.09 |
| Mar 31, 2024 | -0.98 |
| Dec 31, 2023 | -2,855.43 |
| Sep 30, 2023 | -0.92 |
| Jun 30, 2023 | -13.45 |
| Mar 31, 2023 | -11.14 |
| Dec 31, 2022 | 16.19 |
| Sep 30, 2022 | 0.53 |
| Jun 30, 2022 | 7.02 |
| Mar 31, 2022 | 0.25 |
| Sep 30, 2021 | -3.65 |
| Mar 31, 2021 | -2.33 |